检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Efficacy and safety of canakinumab, a long acting fully human anti-Interleukin-1β antibody, in systemic juvenile idiopathic arthritis with active systemic features: results from a phase III study

N Ruperto,H Brunner, G Horneff, P Quartier,T Constantin,Y Berkun,M Erguven,T Kallinich,R Brik,NM Wulffraat,MA Ferrandiz, L Rutkowska-Sak, H Ozdogan, L McCann, K Lheritier, R Preiss, L Tseng,A Martini,DJ Lovell

Pediatric Rheumatology（2011）

引用 6|浏览10
暂无评分
关键词
Placebo,Prednisone,Disease Duration,Secondary Endpoint,Active Joint
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要